A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires
Talon Metals Corp announced a landmark six-year deal with Tesla Inc (NASDAQ:TSLA) to supply the electric vehicle manufacturer with nickel concentrate from its Tamarack nickel project in Minnesota, US. According to a statement from Talon, Tesla has committed to buying 75,000 metric tonnes of nickel in concentrate. The Elon Musk-led company also has a preferential right under the agreement to negotiate the purchase of additional nickel concentrate beyond the 75,000-ton commitment.
Gratomic Inc has announced that it has initiated manufacturing on the Air Classification units for its Aukam Graphite Project processing plant in Namibia. The Toronto-based company said the secondary enrichment program completes engineering of the upgrading circuit on the refining section of the plant. It noted that Air Classification is a unique feature of the Aukam processing plant, allowing the company to take advantage of the singular properties of vein graphite in a very effective and ecologically friendly manner, upgrading the carbon content at both the feed-end of the plant, and at the final upgrading circuit post-processing. “Air Classification is one of the many things that surfaced from the out-of-the-box thinking mentality of our team, and will help set us apart from the pack in the graphite community,” Gratomic’s chief operating officer and head of graphite marketing and sales Armando Farhate said in a statement.
Skye Bioscience inc (OTCQB:SKYE) issued a letter to its shareholders written by CEO Punit Dhillon, highlighting the achievements of 2021 and providing the business outlook for 2022. “2021 represented an important year of fundamental progress for Skye,” Dhillon said. “We further strengthened our team and work towards completing the preclinical development necessary to advance SBI-100 into the clinic. Our preclinical research to date gives us confidence that SBI-100 can be a promising drug candidate to treat glaucoma, the world’s leading cause of irreversible blindness.” For 2022, Dhillon told investors that the company is preparing to make significant headway with the clinical development of SBI-100, the expansion of its R&D program, and the placement of resources and capabilities to support the escalating contributions toward disruptive innovation in the development of pharmaceutical cannabinoids. The CEO said that in 2022, the company is looking to complete a Phase I study to establish the safety and tolerability of SBI-100 in humans. It will also initiate a robust placebo and active-controlled Phase II study for SBI-100 in glaucoma.
Universal Ibogaine Inc (TSX-V:IBO) has announced that Rami Batal has been replaced as chief executive officer (CEO) of the company and its subsidiaries by Nick Karos, effective immediately. Karos was recently appointed as a capital markets consultant to the company. In a statement, Chief Ian Campbell, chair of the Universal Ibogaine board of directors said: “We are grateful for Rami’s leadership and many contributions. We wish Rami all the best.” Based in Los Angeles, USA, Karos is a seasoned financier whose career includes senior roles with US investment banks, including serving at Piper Jaffray as head of Nasdaq Trading and Agency Services, and most recently as CEO of Private Trading Group, which has provided business development and capital raising services for several successful start-up ventures.
Todos Medical Ltd announced that its President & CEO Gerald Commissiong will appear on Fox Business’ The Claman Countdown on Tuesday, January 11 during the 3pm Eastern Time hour show to discuss COVID testing in the United States and how it relates to the pending availability of oral antiviral treatments such as the company’s Tollovir 3CL protease inhibitor oral antiviral treatment currently preparing to read out on Phase 2 clinical data in hospitalized patients. Commissiong is also presenting at the Biotech Showcase 2022 to be held virtually from January 10-12th, 2022. Concurrent with this announcement, Commissiong released a blog entitled “COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” that discusses key points needed to improve the United States COVID testing infrastructure. The blog posting is available online at https://todosmedical.com/blog/covid-testing-what-needs-to-happen-now-to-turn-the-corner-in-2022.
Burcon NutraScience Corp (TSX:BU, NASDAQ:BRCN) has announced that Johann Tergesen will be stepping down as the company’s president and CEO. Burcon said Tergesen will remain CEO until either a successor is appointed by the company’s board of directors, or no later than February 28, 2022. To ensure an orderly transition, he will continue in an ongoing capacity as an advisor to the company and Burcon’s board of directors. The company added that it has engaged Kincannon & Reed, an executive search firm specialising in the food and agribusiness sectors, to assist in recruiting a new CEO.
Genprex Inc has announced a plan to accelerate the opening of trial sites for the Acclaim-1 clinical trial, which combines the company’s lead product candidate, REQORSA (quaratusugene ozeplasmid) Immunogene Therapy, with AstraZeneca’s Tagrisso as a potential innovative treatment for non-small cell lung cancer (NSCLC). The company said the opening of four clinical trial sites to enroll patients in the Phase 1 portion of Genprex’s Acclaim-1 clinical trial is underway as part of a collaboration agreement with a large network of integrated, community-based oncology practices, with an expectation of opening additional sites in the Phase 2 portion of the study.
Ximen Mining Corp (TSX-V:XIM, OTCQB:XXMMF) has reported drill results from two holes completed last year at its Wild Horse property in British Columbia, which covers potential sources of placer gold deposits, where gold was first discovered in 1864. The drilling was undertaken to extend previous results from a hole in 2016 after surface grab sample results ranged up to 8 grams per tonne (g/t) gold and ‘significant’ gold values were hit. Ximen said previous reports indicated a drill intercept of 0.76 g/t gold over 14.4 metres (m) was obtained between depths of 60m and the end of the hole at 74.4m. The first Ximen hole last year extended the 2016 hole from 74m to 217.6m, and hit continued quartz veinlet stockwork and breccia-style mineralization.
Think Research Corporation said it has attested that its telemedicine software has met the requirements and is now listed on the Virtual Visits Verification site for virtual care within the Ontario health care sector. The Toronto-based company said this means clinicians can confidently use Think’s VirtualCare software to conduct effective virtual appointments through video and secure messaging in compliance with provincial standards. Think Research noted that Ontario Health has established mandatory requirements as part of the provincial standard for Virtual Visits Verification solutions for use within the Ontario health care sector. The provincial standards ensure virtual care solutions meet the highest criteria appropriate for clinical use in order to receive official verification, it added.
Hawkmoon Resources Corp (CSE:HM) CEO Branden Haynes has told shareholders that the exploration firm is well-funded to progress drilling at its primary Wilson property in the Abitibi greenstone belt in Quebec. The junior company raised C$3.4 million in 2021, it’s first as a publicly-traded entity following its initial public offering on the Canadian Securities Exchange in April. The Wilson property features a cluster of seven gold showings in the prolific gold district of Quebec. Haynes said that Hawkmoon is planning to drill another 5,000 metres at Wilson in 2022, having secured its first choice of drilling contractor.
Starton Therapeutics Inc said it has received its first Clinical Trial Authorization in the Netherlands to start a Phase 1 study on its STAR-LLD continuous delivery lenalidomide. STAR-LLD is a continuous delivery lenalidomide in development to expand the standard of care for the most common blood cancers, multiple myeloma and chronic lymphocytic leukemia (CLL). The study will evaluate the 24-hour bioavailability, safety, tolerability and pharmacokinetics in human subjects compared to oral lenalidomide.
Safe-T Group (NASDAQ:SFET) Ltd announced that it has reached a monthly recurring revenue (MRR) milestone for its recently-introduced privacy solution for Apple mobile devices via the App Store, ending 2021 with more than 10,000 paid subscribers worldwide. The company also said it has experienced a more than 50% increase in subscription revenue quarter over quarter as adoption of its consumer privacy product accelerates. “The growth in our consumer business is a significant factor behind our expected record 2021 financial performance announced last week, driving our full-year revenue above $10 million, a year-over-year growth of more than 100%,” Safe-T Group (NASDAQ:SFET) CEO Shachar Daniel said in a statement
District Metals Corp has reported new assay results from its Svärdsjö property in the Bergslagen Mining District of south-central Sweden that showed high grades of polymetallic mineralization. Chip sampling from the Kompanigruvan pit near the historic mine returned 37.3% zinc equivalent, comprised of 253 grams per ton (g/t) silver, 22.8% zinc, 8.6% lead, 0.1 g/t gold and 0.02% copper. In addition, grab samples from mine dumps at the Stormyrgruvan showing and a historic pit at the Hagsfallgruvan showing included 29% zinc equivalent (133 g/t silver, 15.7% zinc, 7.8% lead, 0.1 g/t gold and 1% copper) and 18.3% zinc equivalent (58.2 g/t silver, 9.8% zinc, 7.1% lead, 0.1 g/t gold and 0.2% copper), respectively.
Beyond Medical Technologies Inc, through its medical face mask manufacturing subsidiary Micron Technologies Inc, urged its clients to utilize medical-grade face masks in social settings as the highly contagious Omicron coronavirus (COVID-19) variant sweeps across the world. Since August 2020, Micron Technologies has been operating at its facility in Delta, British Columbia, where it manufactures medical-grade face masks under its Medical Device Establishment license issued by Health Canada. Micron is also registered with the US Food and Drug Administration (FDA).
CytoDyn Inc has highlighted a research paper which indicates that its flagship drug leronlimab shows activity against 4-Class drug-resistant HIV-1 from heavily treatment-experienced (HTE) subjects. The Vancouver, British Columbia-based company noted that the research paper entitled “Leronlimab (PRO 140) activity against 4-class drug-resistant HIV-1 from Heavily Treatment Experienced Subjects” has been accepted, peer-reviewed and is available as a journal pre-proof on ScienceDirect. “We would like to thank our Italian colleagues for understanding the importance of leronlimab in the treatment of HIV. This is further proof that leronlimab can benefit CCR5 tropic HIV patients, including those patients with multidrug resistance. HIV patients deserve the opportunity for multiple, effective treatment options,” said Scott A. Kelly, CytoDyn’s chief medical officer.
Trust Stamp (OTCQX:IDAI, EURONEXT:AIID) Inc, a provider of AI-powered trust and identity services across multiple industries, has outlined several achievements as it reported a positive year-end review of 2021, characterized by significant company-wide growth. The Atlanta, Georgia-based company noted that its momentum coming out of 2021 has positioned it to further accelerate growth, with the capital, team, technology, clients, and prospects needed to target another record year. “The 2021 fiscal year was exciting and transformational for Trust Stamp (OTCQX:IDAI, EURONEXT:AIID),” CEO Gareth Genner said in a statement. “Despite exceptional market conditions, we were able to achieve record growth in every aspect of our business, from our team size and our intellectual property portfolio to our prospect and client base, and notably, in our market capitalization and revenue,” he added.
DGTL Holdings Inc has announced the closing of a second and final tranche of its previously announced private placement offering of subscription receipts after the closing of its first and tranche on December 7, 2021. Under the final tranche, the company issued 38 subscription receipts at an offering price of $1,000 each, for aggregate gross proceeds of $38,000, bringing the total number of subscription receipts issued under the offering to 1,068 for aggregate total gross proceeds of $1,068,000. DGTL noted that completion of the offering satisfied a key condition to closing in the arrangement agreement between the company and Engagement Labs (TSX-V:EL) Inc, dated August 11, 2021.
Recruiter.com Group Inc said its latest Recruiter Index for December 2021 has revealed that, after dipping in November, candidate and recruiter sentiments rose over the month. Nearly 37% of recruiters noted an increase in applicant volume this month, jumping 60% since November, the company said. The amount of remote roles recruiters have been working to fill increased by 29% in December, surpassing hybrid roles for the first time. This could be a result of new variants being introduced and the end of seasonal hiring, the company added. Recruiter.com’s CEO, Evan Sohn, said he believes the recruitment sector is starting to see the ‘great alignment’ as the number of candidates prioritizing remote work and the number of remote positions increase.
Vuzix Corporation (NASDAQ:VUZI), a supplier of smart glasses and Augmented Reality (AR) technology, has announced that it will be participating in two upcoming virtual investor conferences in January. “Institutional investors are welcome to schedule one-on-one meetings with management via the respective conference website or their sales contact,” said the company. On January 14, 2022, Vuzix will participate in the 24th Annual Needham Virtual Growth conference. Vuzix CEO Paul Travers will share his industry and company insights at 10.00am ET. The presentation will be webcast live and available for replay at https://wsw.com/webcast/needham116/vuzi/2304588 or at https://ir.vuzix.com/. On January 19, 2022, Vuzix will participate in the BTIG Metaverse Unbound Conference where Vuzix CEO Travers will share his insights during a fireside chat to be held at 12.00pm ET. The presentation will be webcast live and be available for replay through Friday, January 21, 2022, through registration at https://btig.meetmax.com/sched/event_80021/conference_register.html.
Xigem Technologies (CSE:XIGM, OTCQB:XIGMF) Corporation, a tech provider for the remote economy, revealed that it has signed a definitive asset purchase agreement with 2747524 Ontario Inc, operating as Cylix Data Group (CDG), a business intelligence firm, for its previously announced acquisition of the assets of CDG, for around C$32.35 million. The Toronto-based technology company signed the definitive agreement on January 7, 2022. “Formal closing of the transaction is expected to occur by or around January 21, 2022,” said the company. Cylix Data is a business-to-business intelligence technology company which has software that boosts efficiency and productivity for executives by giving them information at their fingertips to help key decision-making and risk-management. The proprietary database of over 74 million data points has been pulled from both third-party vendors and internally originated sources.
Argentina Lithium & Energy Corp (TSX-V:LIT, OTCQB:PNXLF) said it has expanded its footprint at the Pocitos project in Salta province to more than 26,000 hectares (Ha) by striking three cash and share option deals with local vendors. “Pocitos, one of the largest salars within Argentina’s Lithium Triangle, remains a key under-explored salar in Salta,” Nikolaos Cacos, the CEO of the company told investors in a statement. “With these new acquisitions, we are now the largest holder of claims in this very prospective basin.” Following a January 3, 2022, agreement, Argentina Lithium said it can acquire a 100% interest in the 1,602 Ha ‘El Pidio GIII’ property in the southeast of the Pocitos basin by paying US$165,000 in cash over three years, including a mandatory US$30,000 over the first 18 months.
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) has revealed a new milestone in its artificial intelligence-powered drug discovery program. The company announced it had completed a target-based model of serotonin receptor 5-HT2A, which will allow the company to quickly screen billions of compounds. Mydecine said the model will help the company to understand the novel compounds that are most likely to increase binding ability, thus improving second and third-generation psychedelic molecules.
Mountain Boy Minerals Ltd (TSX-V:MTB, OTCQB:MBYMF) has announced further encouraging results from its 2021 field program on the BA project which included drilling, geologic mapping, prospecting, and channel sampling. The Vancouver-based company said mapping and prospecting on the BA project beyond the area of drilling generated three new exploration targets which emphasize the unexplored potential of this prospective 10,658-hectare property. The BA project, located in British Columbia’s Golden Triangle, is 29 kilometres (km) by road from the deep-water seaport in Stewart. Highway 37A and a high voltage transmission line run through the northern end of the property. Drilling on the Barbara zone from 2006 to 2010 outlined an extensive zone of silver-lead-zinc mineralization.
Canntab Therapeutics Limited, a leading innovator in cannabinoid and terpene blends in hard pill form, has provided an update on its successful product deliveries for Ontario and Australia, which augur well for the commercialization of the company’s brand and products. On January 7, 2022, Canntab completed its first shipment of 5 mg THC tablets to the Ontario Cannabis Store (OCS). Additionally, in early December 2021, Canntab completed its second shipment of both THC and CBD tablets to Australia. In a statement, Canntab CEO Larry Latowsky said: “Our initial delivery to the OCS is a first for us and marks the beginning of a productive and growing relationship. Our product will be available to all Ontario Cannabis stores for purchase, in addition to being available for sale via the OCS website.”
Levitee Labs (CSE:LVT) Inc said it has entered into a strategic partnership via a service agreement with Canntab Therapeutics Limited to contribute towards correcting the opioid crisis in Canada. Under this partnership, Levitee will inform customers throughout its ecosystem of specialized clinics and pharmacies in Alberta and British Columbia about Canntab products as alternative solutions for pain management, addiction, and other disorders. “We share a vision with Canntab to play a meaningful role in flattening the curve of the opioid crisis in Canada by tapering the use of addictive painkillers through the substitution of viable alternatives, which can include cannabinoids like CBD and THC and a combination thereof,” said Noha ElSayed, executive director, Levitee Clinics and Levitee Pharmacies, Alberta Region.
Canada Silver Cobalt Works Inc has announced a continued expansion at Castle East in Ontario with strong intercepts of high-grade silver and cobalt from the 61 Zone. The Coquitlam, British Columbia-based company’s Castle property is located near the town of Gowganda, 80 kilometers (km) west-northwest of Temiskaming Shores, Ontario, Canada. The property is 15 km east of Aris Gold Corp’s Juby Gold deposit, 30 km due south of Alamos Gold’s Young-Davidson mine, and in the vicinity of Kirkland Lake Gold’s Macassa complex, and new gold discoveries in the Timmins West area. The company highlighted that 61 Zone grades include 2,571.53 grams per tonne (g/t) silver over 0.50 metres (m), and 1.12% cobalt over 0.51m in hole CS-21-77W1, as well as 1,951.82 g/t silver over 0.55m, and 0.76% cobalt over 0.46m in hole CS-21-77.
FansUnite Entertainment Inc (CSE:FANS, OTCQX:FUNFF) has announced that its American Affiliate division is now authorized to provide customer acquisition services for licensed sports betting operators in New York state. The company said American Affiliate will now bring its team and brands into New York to help drive new depositing customers to its sportsbook partners. “American Affiliate is uniquely well-positioned to help our sportsbook partners achieve their primary goal: securing market share in the largest online sports betting market in the US,” American Affiliate CEO Chris Grove said in a statement.
O3 Mining Inc (TSX-V:OIII, OTCQX:OIIIF) has reported the latest drill results from its 2021 program at the Marban project in Val-d’Or, Québec, which, it said, augurs well for an updated resource for the property earmarked for release in the first quarter this year. The assays hail from 15 holes sunk in and around the Marban open-pittable deposits and focused on the so-called Marban and Norlartic zones. O3 noted there were still 1,662 assays pending from last year’s infill program from 32 holes, which are expected to be released in coming weeks. Hailing the latest set of data, CEO Jose Vizquerra told investors in a statement: “Not only do the results offer us the potential to expand the overall scope of the project, but we are also seeing higher grades than the average resource grade, which we are confident will be reflected in our updated mineral resource in early 2022 and will be an important component in the completion of Marban’s pre-feasibility study.”
PowerTap Hydrogen Capital Corp has announced that its 49%-owned subsidiary, AES-100 Inc, a leading clean hydrogen technology company, has initiated design and development activities for a green-hydrogen home power unit. The company said the unit is being sized for applications to meet the needs of average North American households, revolutionizing green power production. It noted that the global addressable market for hydrogen is estimated to be about US$150 billion at present but is estimated to reach over US$600 billion by 2050. With nearly 140 million homes in the US alone, the market opportunity is both tremendous and transformative, it added.
Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) has told investors that the process plant at its flagship Segilola gold project in Nigeria is now running continuously at design capacity following supply chain issues that affected operations. In an operational and production update, Thor confirmed the issues have been resolved, the laboratory has been fully commissioned and gold shipments have been made successfully. It noted that 61,128 tons of ore were processed in December 2021 with a head grade of 3.4 grammes per tonne (g/t). On November 30, 2021, the company said the combination of a delay in commissioning of the project, late arrival of laboratory equipment, supply chain issues resulting in the supply of sub-standard reagents, and delays in its ability to export produced gold resulted in it having to restrict the plant feed grade to an average of 2 g/t.
Milestone Scientific Inc (NYSE:MLSS) has prepared investors for an 85% increase in revenue for its 2021 financial year as its dental and medical divisions continue to gain traction. The company said it expects revenue of over $2.6 million for the fourth quarter of 2021, up from $2.2 million in 4Q 2020, while full-year revenue is likely to be more than $10 million compared to revenue of $5.4 million for fiscal 2020. “This growth is due in part to the success of our sales and marketing initiatives within the dental division, as well as the addition of new distributors,” President and CEO Arjan Haverhals said in a statement. “We are also gaining momentum within our medical division, reflecting the early success of our commercial initiatives as we begin to penetrate large hospitals, healthcare systems and pain management clinics with our CompuFlo Epidural and CathCheck Verification System”, he added.
Nova Royalty Corp has said it is set to buy an existing 0.135% net smelter return (NSR) royalty on Hudbay Minerals’ Copper World and Rosemont copper projects in Arizona, USA, in a deal worth around US$5.5 million. The company has struck a royalty purchase agreement with arm’s length sellers over the transaction, which covers the Copper World asset, only discovered in 2020, and which already boasts an initial resource of 400 million tonnes. The deal also includes a right of first refusal (ROFR) on a further 0.540% NSR also owned by the vendors covering the same royalty area. “This acquisition further demonstrates Nova’s consistent success in executing on our strategy of locking in royalties on the next generation of the world’s most strategic copper projects,” said Alex Tsukernik, Nova’s CEO in a statement.
Wishpond Technologies Ltd has announced the appointment of David Pais as the company’s chief financial officer (CFO), effective immediately. Reporting directly to Ali Tajskandar, chairman and CEO of Wishpond, Pais will have responsibility for all finance, accounting, financial reporting, audit, tax and capital planning functions. He will assume the CFO role from Juan Leal, who will continue to support the company in an M&A-related advisory role. The company noted that Pais is an experienced, growth-oriented CFO, having worked at several technology companies in Vancouver over the last twenty years.
FPX Nickel Corp (TSX-V:FPX) has announced the appointment of Erin Wilson as the company’s new principal geologist. FPX Nickel said Wilson will lead the exploration activities and advancement of the geological understanding of FPX’s projects, including the Preliminary Economic Assessment (PEA)-stage Decar Nickel District in British Columbia. “Erin has a strong track record of leading exploration teams in both supervisory and management roles, having planned, managed and executed work programs covering early-stage, resource-stage and production-stage assets,” FPX Nickel Vice-President, projects Andrew Osterloh said in a statement.
Royal Wins Corporation (CSE:SKLL, OTCQB:RYWCF) announced that Luis Goldner, a leading gaming technology executive, has been appointed to the company’s high-profile Advisory Board. The company noted that Goldner is a seasoned corporate executive who has managed and operated Fortune 500 companies in the Americas with a focus on global partnerships, consumer trends, and operational best practices. It said he has been a pioneer in bringing Smart Card technology to Brazil and has over 12 years’ experience in lottery and gaming industry, including serving as CEO for Intralot do Brazil which he grew to become the number one lottery operator in Brazil. Goldner is currently serving as the chief operating officer of digital media company ICARO Media Group based in New York. In a statement, Royal Wins chairman Charles Vycichl commented: “The depth of our Advisory Board is an acknowledgment of the potential Royal Wins has to become a global trendsetter in responsible, best-practices real-money, pure-skill hyper-casual gaming. We are positioned to make a real impact in the constantly growing world of gaming, and Mr. Goldner’s combination of industry leadership experience and a track record of managing global growth strategies makes Luis an ideal candidate to help Royal Wins achieve just that.”
Xphyto Therapeutics Corp said it has made two key appointments to continue its focus on research, development and commercialization of its biosensor and diagnostic products, including for the detection of coronavirus (COVID-19). The Vancouver and Germany-based bioscience accelerator said Roland Spleiss has joined as its director of business development while Dr Heinrich Jehle has joined as head of diagnostic research. “Mr Spleiss and Dr Jehle are tremendous additions to the XPhyto team,” Professor Dr Thomas Beckert, the managing director of XPhyto subsidiary XP Diagnostics, said in a statement. “Mr Spleiss brings robust knowledge and experience in the development of product sales and economic optimization with a demonstratable track record of success. Dr Jehle’s scientific expertise ensures the continued advancement and commercialization of innovative biosensor and diagnostic products, which is a key component of XPhyto’s short- and long-term success.”
Ketamine One (NEO:MEDI.AQN) Capital Ltd has announced that its wholly-owned contract research organization, KGK Science Inc, has become the first founding sponsor of the Psychedelic Science 2023 event. The Vancouver, British Columbia-based company said that the event, scheduled for June 19-25, 2023, in Denver, Colorado with an estimated 10,000 attendees, will be the world’s largest gathering of the psychedelic ecosystem. The event will be hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) and is being organized by Momentum Events, the company said.
Progressive Planet Solutions Inc (TSX-V:PLAN) said it has received conditional approval from the TSX Venture Exchange (TSXV) for the acquisition of Absorbent Products Ltd and also announced that its common shares will resume trading at the open of markets on January 11, 2022. “Today marks another important milestone for Progressive Planet, having received conditional approval from the TSXV for the acquisition of Absorbent Products Ltd,” said Steve Harpur, CEO of Progressive Planet. “With the conditional approval, management is now fully focused on finalizing the terms of the bank financing required to complete this transaction and to completing the previously announced private placement,” he added. The company said it will provide further information regarding the bank financing once available. Completion of the proposed transaction remains subject to, among other things, final approval by the TSXV and fulfillment of TSXV requirements. There is no assurance or guarantee that the acquisition will be completed as described or at all, the company said.
i-80 Gold Corp noted that its CEO, Ewan Downie has reported on System for Electronic Disclosure by Insiders (SEDI) recent purchases of common shares of the company through open market purchases on the Toronto Stock Exchange to increase his share ownership to 5,000,027 or 2.09%. Since the Company commenced trading on April 14, 2021, Downie has purchased more than 1.4 million shares of i-80 to reach an ownership milestone rarely held by executives of publicly-traded companies in the mining sector. “Since the inception of the Company less than one year ago, we have closed multiple major transactions that position i-80 as one of the largest holders of gold and silver resources in Nevada”, said Downie. “We have secured a strong balance sheet including nearly US$200 Million in cash and cash equivalents following funding of the previously announced financing package and have embarked on a peer-best production growth initiative in the world’s most favorable mining jurisdiction”.
NetCents (CSE:NC, OTCQB:NTTCF, Frankfurt Code :26n) Technology Inc announced that Jenn Lowther has accepted the position of company president. Lowther has served as the company’s chief revenue officer since 2018 and was chief marketing officer previous to that. She is responsible for managing many of the key projects of recent years including the company’s global banking and remittance strategy, streamlining the merchant sign-up and onboarding process, its global expansion strategy, and developing and implementing comprehensive compliance policies and procedures. The company said the decision to elevate Lowther to president is a reflection of her capabilities in managing all aspects of the NetCents (CSE:NC, OTCQB:NTTCF, Frankfurt Code :26n) businesses.
As well, the company has announced the appointment of Gaurav Mohan as its chief revenue officer. The company noted that Mohan, who has previously served as the director of customer and partners success at Ripple, will oversee revenue operations and facilitate long-term strategic planning. He will fill the vacancy created by the promotion of Jenn Lowther to president of the company. As chief revenue officer, NetCents (CSE:NC, OTCQB:NTTCF, Frankfurt Code :26n) said Mohan brings his extensive fintech and cryptocurrency skillset, as well as his deep relationships across the industry. Apart from Ripple, it noted he has previously worked in progressive technology and financial services roles at a variety of fintech companies, including Clovity, and HSBC.
Nevada Silver Corporation (TSX-V:NSC) said it has obtained approval for trading on the OTCQB, a US trading platform operated by OTC Markets Group in New York. The company’s common stock will officially commence trading today, January 10, 2022, on the OTCQB under the ticker symbol NVDSF. Gary Lewis, CEO at Nevada Silver said: “With two US-based exploration projects, expanding our reach into the US institutional and retail investment community was a logical extension of our investor relations strategy. The OTCQB listing will greatly enhance visibility and liquidity in one of the largest investor markets globally.”
Numinus Wellness Inc has said it is rescheduling its Q1 2022 results conference call and reporting of its Q1 2022 financial results to after the market close on January 20, 2022 (previously January 13, 2022). This change is a result of staffing challenges related to coronavirus (COVID-19). Interested parties are invited to participate in the company’s Q1 2022 results conference call and webcast, occurring on January 20, 2022, at 5.30pm Eastern time / 2.30pm Pacific time. During the call, Numinus executives will review the company’s performance and recent initiatives, and answer questions from analysts. To listen to the live webcast, investors should register at: https://event.on24.com/wcc/r/3574506/6105A28282486D6F95F7834E9C5632E2. The webcast will also be archived on the Events and Presentations page of Numinus’ Investor Relations website: https://www.investors.numinus.com/events-and-presentations. To participate in the live conference call, investors should use the following dial-in information: 1 (833) 989-2968 (Toll-free North America); 1 (236) 714-4028 (International); conference passcode 2670376. A replay of the conference call can also be accessed after 8.30pm Eastern time / 5.30pm Pacific time on Thursday, January 20, 2022, at 1-800-585-8367 or 1-416-621-4642 (using passcode 2670376). The replay will be available until February 3, 2022.
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) said it has engaged JBN Partners, LLC to increase public awareness of and interest in the company, its management and its products by coordinating certain investor relations and corporate financial public relations with members of the investment community, the financial media and the public, in general. The services agreement with JBN has a six-month term with a total payment value of US$150,000.
Sigma Lithium Corp (TSX-V:SGML, OTCQB:SGMLF, NASDAQ:SGML) said that Ana Cabral-Gardner, its co-CEO is scheduled to present at the Bank of America (NYSE:BAC) Securities Virtual Battery and Storage Conference today, January 10, 2022, at 11.15am ET via the following webcast link: https://bofa.veracast.com/webcasts/bofa/batterystorage2022/id6B9yZs.cfm. Cabral-Gardner will also host one-on-one meetings throughout the day on Monday, January 10.
TREES Corporation has said it is set to ring the opening bell at the NEO Exchange on Tuesday, January 11, 2022, at 9.20am ET. Investors can register to view the event at: https://neostockexchange.zoom.us/webinar/register/1216414811096/WN_Jf1Ils7LRJ2ih4pXxlxD0A
CleanSpark Inc (NASDAQ:CLSK) has announced that Its CEO Zach Bradford will participate in a Valkyrie Investments webinar on sustainable bitcoin mining Thursday, January 13, 2022, at 12.30pm ET. The event is the first of Valkyrie’s new Spotlights webinar series. Spotlights feature deep dive firesides with special guests. Bradford will be joined by mining expert Kristy-Leigh Minehan. This virtual event is open to the public. Interested participants can register here: https://valkyrieinvest.com/webinars/spotlights/
Co-Diagnostics (NASDAQ:CODX) Inc has announced today that the company will be featured at the H.C. Wainwright & Co. 2022 BioConnect Conference, being held virtually on January 10-13. Dwight Egan, Co-Diagnostics (NASDAQ:CODX) CEO, will be conducting an On-Demand presentation discussing recent company events related to its forthcoming point-of-care and at-home diagnostic platform, and acquisition of the entities previously working with Co-Diagnostics (NASDAQ:CODX) on the development of the platform. The presentation can be accessed on the Events and Webcasts section of the Co-Diagnostics (NASDAQ:CODX) website – https://ir.codiagnostics.com/events-webcasts – beginning January 10, 2022, at 7:00 am Eastern Time for institutional investors who have registered for the event. via the following link: https://hcwevents.com/bioconnect/
PsyBio Therapeutics Corp has announced that Evan Levine, its chief executive officer and chairman, will present at the H.C. Wainwright Bioconnect Conference on Monday, January 10, 2022, on-demand beginning at 7.00am Eastern Time via the following link: https://journey.ct.events/view/2128e196-5384-4b9d-be88-ecc20ada1cc1. A recording of the presentation will be accessible via the same link for 90 days. To schedule a meeting with the PsyBio management team, investors can contact KCSA Strategic Communications by emailing firstname.lastname@example.org.
Vyant Bio (NASDAQ:VYNT) Inc has announced that it will be participating in the H.C. Wainwright Bioconnect Conference which is being held virtually from January 10-13, 2022. Registered attendees can access the recorded presentation on-demand (24×7) for the duration of the conference, and investors can register via the following link: https://hcwevents.com/bioconnect/. During the presentation, Vyant Bio (NASDAQ:VYNT)’s chief executive officer, Jay Roberts, and its chief scientific officer, Dr Robert Fremeau will be discussing key highlights from 2021 and the scientific, business and strategic outlook for 2022. The presentation will be an archived recording will be made available in the Investors’ section of the Vyant Bio (NASDAQ:VYNT) website. Vyant Bio (NASDAQ:VYNT) will also be available for virtual outside 1:1 meetings after the H.C. Wainwright Bioconnect Conference. Investors can contact Dr Jennifer K. Zimmons at email@example.com or +1 917.214.3514 for scheduling.
OTC Markets Group Inc, the operator of financial markets for over 11,000 US and global securities, has announced that Tofutti Brands Inc, the developer and marketer of TOFUTTI brand vegan cheese and frozen desserts, has qualified to trade on the OTCQX Best Market and has upgraded from the OTCQB Venture Market. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. “Tofutti Brands is proud to make this step up to the OTCQX. We believe that having our shares traded on the OTCQX will generate greater visibility for our company and will allow us to gain a broader investor base,” said Steven Kass, chief executive officer of Tofutti Brands.